Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

1 terminated/withdrawn out of 2 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT05931848Not ApplicableTerminated

Otago Home-Based Exercise Program in Community-Dwelling Older Women (METCOHEP Study)

Role: collaborator

NCT04254159Not ApplicableCompleted

The Effects of Neuromuscular Electrical Stimulation in Older Patients With Asthma

Role: collaborator

All 2 trials loaded